Peripheral monocytes of obese women display increased chemokine receptor expression and migration capacity

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 7, 2014, Pages 2500-2509

  Krinninger, P ^a   Ensenauer, R ^d   Ehlers, K ^a   Rauh, K ^a,f   Stoll, J ^a   Krauss Etschmann, S ^e   Hauner, H ^a,b,c   Laumen, Helmut ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^e UNIVERSITY OF MUNICH   (Germany)

^f Comprehensive Pneumology Center Helmholtz Zentrum München Ludwig Maximilians University ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR3; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RANTES; TRIACYLGLYCEROL;

ADULT; AGE; ARTICLE; BODY COMPOSITION; CASE CONTROL STUDY; CELL MIGRATION; CELL POPULATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOCOMPETENT CELL; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MONOCYTE; NORMAL HUMAN; OBESITY; PERIPHERAL BLOOD MONONUCLEAR CELL; PERIPHERAL MONOCYTE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TRIACYLGLYCEROL BLOOD LEVEL; WAIST HIP RATIO;

ADULT; CASE-CONTROL STUDIES; CHEMOTAXIS, LEUKOCYTE; FEMALE; GENE EXPRESSION; HUMANS; IDEAL BODY WEIGHT; MONOCYTES; OBESITY; RECEPTORS, CHEMOKINE; THINNESS; UP-REGULATION;

EID: 84904045292     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-2611     Document Type: Article

References (41)

1. Winer S, Winer DA. The adaptive immune system as a fundamental regulator of adipose tissue inflammation and insulin resistance. Immunol Cell Biol. 2012;90:755-762.
2. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003;112:1796-1808. (Pubitemid 38063703)
3. Woollard KJ, Geissmann F. Monocytes in atherosclerosis: subsets and functions. Nat Rev Cardiol.2010;7:77-86.
4. Mohanty P, Hamouda W, Garg R, Aljada A, Ghanim H, Dandona P. Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. J Clin Endocrinol Metab. 2000;85:2970-2973. (Pubitemid 32269184)
5. Ghanim H, Aljada A, Hofmeyer D, Syed T, Mohanty P, Dandona P. Circulating mononuclear cells in the obese are in a proinflammatory state, Circulation. 2004;110:1564-1571. (Pubitemid 39297977)
6. Crujeiras AB. Differential expression of oxidative stress and inflammation related genes in peripheral blood mononuclear cells in response to a low-calorie diet: a nutrigenomics study. OMICS. 2008;12:251-261. (Pubitemid 352773935)
7. Kanda H, Tateya S, Tamori Y, et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest. 2006;116:1494-1505.
8. Kamei N, Tobe K, Suzuki R, et al. Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J Biol Chem. 2006;281:26602-26614. (Pubitemid 44401869)
9. Ito A, Suganami T, Yamauchi A, et al. Role of CC chemokine receptor 2 in bone marrow cells in the recruitment of macrophages into obese adipose tissue. J Biol Chem. 2008;283:35715-35723.
10. Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest. 2007;117:175-184. (Pubitemid 46048464)
11. Keophiphath M, Rouault C, Divoux A, Clement K, Lacasa D. CCL5 promotes macrophage recruitment and survival in human adipose tissue. Arterioscler Thromb Vasc Biol. 2009;30:39-45.
12. Huber J, Kiefer FW, Zeyda M, et al. CC chemokine and CC chemokine receptor profiles in visceral and subcutaneous adipose tissue are altered in human obesity. J Clin Endocrinol Metab. 2008;93:3215-3221.
13. Jialal I, Huet BA, Kaur H, Chien A, Devaraj S. Increased Toll-like receptor activity in patients with metabolic syndrome. Diabetes Care. 2012;35:900-904.
14. Eckel RH, Alberti KG, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2010;375:181-183.
15. Matthews DR. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419. (Pubitemid 15018832)
16. Harner S, Noessner E, Nadas K, Leumann-Runge A, et al. Cord blood Vα24-Vβ11+ natural killer T cells display a Th2-chemokine receptor profile and cytokine responses. PLoS ONE. 2011;6:e15714.
17. Krinninger P, Brunner C, Ruiz PA, et al. Role of the adipocyte-specific NF-κB activity in the regulation of IP-10 and T cell migration. Am J Physiol Endocrinol Metab. 2011;300:E304.
18. Ziegler-Heitbrock L. The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J Leuk Biol. 2006;81:584-592. (Pubitemid 46393535)
19. Herder C, Hauner H, Kempf K, Kolb H, Skurk T. Constitutive and regulated expression and secretion of interferon-γ-inducible protein 10 (IP-10//CXCL10) in human adipocytes. Int J Obes. 2006;31:403-410.
20. Skurk T, Mack I, Kempf K, Kolb H, Hauner H, Herder C. Expression and secretion of RANTES (CCL5) in human adipocytes in response to immunological stimuli and hypoxia. Horm Metab Res. 2009;41:183189.
21. Madani R, Karastergiou K, Ogston NC, et al. RANTES release by human adipose tissue in vivo and evidence for depot-specific differences. Am J Physiol Endocrinol Metab. 2009;296:E1262-E1268.
22. Poitou C, Dalmas E, Renovato M, et al. CD14dimCD16+ and CD14+CD16+ monocytes in obesity and during weight loss. Arterioscler Thromb Vasc Biol. 2011;31:2322-2330.
23. Rogacev KS, Ulrich C, Blomer L, et al. Monocyte heterogeneity in obesity and subclinical atherosclerosis Eur Heart J. 2010;31:369-376.
24. Weber C, Belge KU, von Hundelshausen P, et al. Differential chemokine receptor expression and function in human monocyte subpopulations. J Leuk Biol. 2000;67:699-04.
25. Weisberg SP, Hunter D, Huber R, et al. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest. 2006;116:115-124. (Pubitemid 43121796)
26. Pandzic Jaksic V, Gizdic B, Miletic Z, Trutin-Ostovic K, Jaksic O. Association of monocyte CCR2 expression with obesity and insulin resistance in postmenopausal women. Clin Invest Med. 2013;36:E24-E31.
27. Kitade H, Sawamoto K, Nagashimada M, et al. CCR5 plays a critical role in obesity-induced adipose tissue inflammation and insulin resistance by regulating both macrophage recruitment and M1/M2 status. Diabetes. 2012;61:1680-1690.
28. Zernecke A, Liehn EA, Gao J, Kuziel WA, Murphy PM, Weber C. Deficiency in CCR5 but not CCR1 protects against neointima formation in atherosclerosis-prone mice: involvement of IL-10. Blood. 2006;107:4240-4243. (Pubitemid 43801346)
29. Majmudar MD, Keliher EJ, Heidt T, et al. Monocyte-directed RNAi targeting CCR2 improves infarct healing in atherosclerosis-prone mice. Circulation. 2013;127:2038-2046.
30. Arkan MC, Hevener AL, Greten FR, et al. IKK-β links inflammation to obesity-induced insulin resistance. Nat Med. 2005;11:191-198. (Pubitemid 40321355)
31. Solinas G, Vilcu C, Neels JG, Bandyopadhyay GK, et al. JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity. Cell Metab. 2007;6:386-397. (Pubitemid 350012000)
32. Bigorgne AE, Bouchet-Delbos L, Naveau S, et al. Obesity-induced lymphocyte hyperresponsiveness to chemokines: a new mechanism of fatty liver inflammation in obese mice. Gastroenterology. 2008;134:1459-1469.e2.
33. Dufour JH, Dziejman M, Liu MT, Leung JH, Lane TE, Luster AD. IFN-γ-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J Immunol. 2002;168:3195-3204. (Pubitemid 34256349)
34. Zernecke A, Shagdarsuren E, Weber C. Chemokines in atherosclerosis: an update. Arterioscler Thromb Vasc Biol. 2008;28:1897-1908.
35. Oh DY, Morinaga H, Talukdar S, Bae EJ, Olefsky JM. Increased macrophage migration into adipose tissue in obese mice. Diabetes. 2011;61:346-354.
36. Kushner I, Rzewnicki D, Samols D. What does minor elevation of C-reactive protein signify? Am J Med. 2006;119:166.e17.
37. Aronson D, Bartha P, Zinder O, et al. Obesity is the major determinant of elevated C-reactive protein in subjects with the metabolic syndrome. Int J Obes Relat Metab Disord. 2004;28:674-679. (Pubitemid 38580975)
38. Han KH, Hong KH, Park JH, et al. C-reactive protein promotes monocyte chemoattractant protein-1-mediated chemotaxis through upregulating CC chemokine receptor 2 expression in human monocytes. Circulation. 2004;109(21):2566-2571. (Pubitemid 38720558)
39. Meng S, Zhang L, Zhao L, et al. Effects of C-reactive protein on CC chemokine receptor 2-mediated chemotaxis of monocytes, DNA Cell Biol. 2012;31(1):30-35.
40. Cancello R, Henegar C, Viguerie N, et al. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes. 2005;54:2277-2286. (Pubitemid 41134253)
41. Kim C, Park H, Kawada T, et al. Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters. Int J Obes Relat Metab Disord. 2006;30:1347-1355. (Pubitemid 44306516)